CardioComm Solutions, Inc.

As of December 31, 2025, CardioComm Solutions, Inc. carries a market capitalization of 2.96M, placing it among publicly traded companies globally. Its enterprise value stands at 3.61M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of December 31, 2025, CardioComm Solutions, Inc. has 197.58M shares outstanding.

These figures are as of December 31, 2025. The price-to-sales ratio is 10.74, and the price-to-book ratio stands at -4.30.

These figures are as of December 31, 2025. The EV/Sales ratio of 13.26 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 3.61M versus a market cap of 2.96M, with the gap driven by net debt and cash on the balance sheet.

As of December 31, 2025, CardioComm Solutions, Inc. maintains a current ratio of 0.17, meaning it holds 0.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -100.26, indicating conservative leverage, while an interest coverage ratio of -11.14 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended December 31, 2025. Return on assets (ROA) is negative at -272.35, reflecting losses generated across the asset base. Inventory turnover of 2.69 indicates how many times CardioComm Solutions, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

As of the close on October 15, 2026, CardioComm Solutions, Inc.'s stock has declined approximately 33.33% over the past 52 weeks. The 50-day moving average sits at 0.02, while the 200-day moving average is 0.04.

Over the twelve months ended December 31, 2025, CardioComm Solutions, Inc. generated 272,158.00 in revenue and converted that into -508,857.00 in net income, yielding earnings per share of 0.00. EBITDA reached -528,458.00, while operating income came in at -557,128.00.

As of December 31, 2025, CardioComm Solutions, Inc. holds 47,043.00 in cash and equivalents against 691,210.00 in total debt, resulting in a net debt position of 617,727.00. Total book value stands at -689,416.00, with working capital of -591,497.00 providing operational flexibility.

CardioComm Solutions, Inc. produced -453,082.00 in operating cash flow over the twelve months ended December 31, 2025.

Over the twelve months ended December 31, 2025, CardioComm Solutions, Inc. posted a gross margin of 81.48, reflecting its pricing power and cost economics. The operating margin of -204.71 and net profit margin of -186.97 provide insight into operational efficiency.

These figures cover the twelve months ended December 31, 2025. Free cash flow yield is negative at -15.50: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -14.80, meaning CardioComm Solutions, Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

CardioComm Solutions, Inc.'s most recent stock split took place on November 26, 2007 with a 5:1 split ratio.

As of December 31, 2025, CardioComm Solutions, Inc. has an Altman Z-Score of -337.43, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.